Johnson's

Main information

  • Trade name:
  • Johnson's Flea and Tick Collar for Dogs, 15% w/ w
  • Pharmaceutical form:
  • Collar
  • Prescription type:
  • AVM-GSL - Authorised Veterinary Medicine – General Sales List
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Johnson's Flea and Tick Collar for Dogs, 15% w/w
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • Dogs
  • Therapeutic area:
  • Ectoparasiticide

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Authorized
  • Authorization number:
  • 05496/4030
  • Authorization date:
  • 21-09-2017
  • Last update:
  • 19-01-2018

Summary of Product characteristics: dosage, interactions, side effects

Revised: June 2018

AN: 00211/2018

SUMMARY OF PRODUCT CHARACTERISTICS

1.

NAME OF THE VETERINARY MEDICINAL PRODUCT

Johnson’s Flea and Tick Collar for Dogs, 15% w/w.

2.

QUALITATIVE AND QUANTITATIVE COMPOSITION

Active substance

% w/w

mg/collar

Dimpylate (as dimpylate stabilised)

15.0

3,600

Excipients

% w/w

mg/collar

Brown collar:

Ferric oxide red (E172)

0.08

19.2

Charcoal, vegetable (E153)

0.02

Blue collar:

Coomassie Brilliant Blue G

0.012

Copper Phthalocyanine

0.012

OB (CAS No. 67210-66-6)

0.005

Red collar:

Rhodamine 6G

0.013

Basic Violet 11

0.005

Yellow collar:

Solvent Yellow 135

0.013

Green collar:

Solvent Yellow 135

0.013

Copper Phthalocyanine Green

0.010

Orange collar:

Disperse Yellow 11

0.010

Rhodamine 6G

0.015

Rhodamine B

0.005

For full list of excipients, see section 6.1

3.

PHARMACEUTICAL FORM

Collar

Coloured flea collar fitted with safety buckle

4.

CLINICAL PARTICULARS

4.1 Target species

Dogs

4.2 Indications for use, specifying the target species

Treatment of dogs infested with fleas (Ctenocephalides felis and C. canis) and

ticks (Ixodes ricinus).

Page 1 of 5

Revised: June 2018

AN: 00211/2018

4.3 Contra-indications

No other insecticide should be used with the collar or within 7 days of removal.

Do not allow the collar to come into contact with nursing females.

Do not use the collar on dogs younger than 12 weeks.

4.4 Special warnings for each target species

Remove collar if any sign of skin irritation occurs.

Check the collar is not too tight, to ensure against irritation.

Do not allow animals to chew the collar.

Remove collar from dog immediately should any signs of drowsiness, listlessness

or respiratory difficulties develop soon after fixing the collar.

4.5 Special precautions for use

(i)

Special precautions for use in animals

For external use only.

Remove fleas from young puppies and nursing females by careful use of

a flea comb.

(ii)

Special precautions to be taken by the person administering the medicinal

product to animals

Do not remove collar from pack until ready to use.

Do not allow children to play with the collar.

Do not allow children to suck or chew the collar.

Do not smoke, eat or drink while handling collar.

Do not sleep with pets wearing collars.

Dimpylate / Diazinon is an organophosphorus compound: DO NOT

handle if under medical advice not to work with

ANTICHOLINESTERASES.

Avoid excessive handling of the collar.

Cut off any excess collar with scissors and dispose of safely.

If you feel unwell after handling the collar, seek medical advice. Wash

hands thoroughly after handling the collar.

(iii) Other precautions

To help prevent reinfestation, animals’ bedding and regular resting areas,

including carpets and soft furnishings, should be treated with a suitable

insecticide and vacuumed regularly.

After fitting the collar, do not allow dogs to swim in ponds or other small

bodies of water. This will not adversely affect the activity of the collar but

is potentially dangerous to aquatic life.

4.6 Adverse reactions (frequency and seriousness)

Typical adverse reactions to organophosphorus compounds are rare.

Page 2 of 5

Revised: June 2018

AN: 00211/2018

4.7 Use during pregnancy, lactation or lay

Do not allow contact with nursing females.

4.8 Interaction with other medicinal products and other forms of interaction

Do not combine with other organophosphorus compounds or medicines which are

not compatible with organophosphorus compounds.

4.9 Amounts to be administered and administration route

One collar per animal to be fastened around the neck. Fasten the collar around

the dog’s neck, ensuring a comfortable fit; two fingers should fit easily under the

collar. Loosen the collar as the dog grows bigger. Cut off excess collar extending

beyond buckle and dispose of with the household refuse. Replace collar after 4

months if flea and tick re-infestation is a risk.

4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary

Symptoms: Tearing, salivation, muscle twitches, vomiting, loss of reflexes, coma,

cyanosis.

Emergency procedure: Remove collar.

Antidote: Atropine.

4.11 Withdrawal period

Not applicable

5.

PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group: Ectoparasiticides for topical use, incl. insecticides

ATC Vet Code: QP53AF03

5.1

Pharmacodynamic properties

The collar is applied around the dog’s neck. The collar constantly releases

dimpylate over a four month period. Fleas and ticks on the skin of the animal

come into contact with the dimpylate and are killed.

5.2

Pharmacokinetic particulars

Dimpylate is an organophosphorus compound with a non-systemic action.

6.

PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Brown collar: Charcoal Vegetable (E153)

Ferric Oxide Red (E172)

Page 3 of 5

Revised: June 2018

AN: 00211/2018

Blue collar: Coomassie Brilliant Blue G

Copper Phthalocyanine

OB (CAS No. 67210-66-6)

Red collar: Rhodamine 6G

Basic Violet 11

Yellow collar: Solvent Yellow 135

Green collar: Solvent Yellow 135

Copper Phthalocyanine Green

Orange collar: Disperse Yellow 11

Rhodamine 6G

Rhodamine B

Polyvinyl chloride

Dibutyl Phthalate

Epoxidised Soya Bean Oil

Calcium Stearate

6.2 Incompatibilities

Morphine, theophylline, aminophylline, large amounts of intravenous fluids,

phenothiazine drugs, pyrantelpalmoate.

6.3 Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years

6.4 Special precautions for storage

Protect from direct sunlight.

Do not store above 25°C.

Do not remove the collar from the pack until you are ready to fit it.

6.5 Nature and composition of immediate packaging

Clear, colourless high-density polyethylene blister, containing one

PVC collar, heat sealed on varnished fibreboard/aluminium

foil/fibreboard laminate backing card.

(ii)

Paper/aluminium foil/low density polyethylene sachet, containing one

PVC collar, packed in a cardboard box.

Page 4 of 5

Revised: June 2018

AN: 00211/2018

6.6

Special precautions for the disposal of unused veterinary medicinal

products or waste materials derived from the use of such products, if

appropriate

Any unused veterinary medicinal product or waste materials derived from such

veterinary medicinal products should be disposed of in accordance with local

requirements.

EXTREMELY DANGEROUS to fish and aquatic life.

Do not contaminate ponds, waterways or ditches with the collar or empty

packaging.

7.

MARKETING AUTHORISATION HOLDER

Beaphar (UK) Ltd

Rook Tree Farm

Withersfield Road

Great Wratting

Suffolk

CB9 7HD

4

8.

MARKETING AUTHORISATION NUMBER

Vm 05496/4030

5

9.

DATE OF FIRST AUTHORISATION

21 September 2017

6

10.

DATE OF REVISION OF THE TEXT

June 2018

Approved: 08 June 2018

Page 5 of 5